| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 40 |
| 1 | ASPIRIN | 17 |
| 2 | ASPIRIN 325 MG | 17 |
| 3 | ASPIRIN 81 MG | 17 |
| 4 | FUROSEMIDE | 15 |
| 5 | METOPROLOL TARTRATE | 15 |
| 6 | ACETAMINOPHEN | 14 |
| 7 | RANOLAZINE | 14 |
| 8 | METOPROLOL | 13 |
| 9 | AMBRISENTAN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IMIPRAMINE PAMOATE | 1 | 0.0061 |
| 1 | PROPAFENONE | 7 | 0.0016 |
| 2 | DOPAMINE HYDROCHLORIDE | 6 | 0.0016 |
| 3 | RANOLAZINE | 14 | 0.0013 |
| 4 | PINDOLOL | 1 | 0.0012 |
| 5 | NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005% | 1 | 0.0010 |
| 6 | CARVEDILOL PHOSPHATE | 3 | 0.0010 |
| 7 | ATROPINE SULFATE INJECTION | 2 | 0.0008 |
| 8 | ATROPINE SULFATE MONOHYDRATE | 2 | 0.0008 |
| 9 | SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM | 1 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 48 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 28 |
| 2 | Endothelin Receptor Antagonist [EPC] | 18 |
| 3 | beta-Adrenergic Blocker [EPC] | 18 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 17 |
| 5 | Corticosteroid [EPC] | 16 |
| 6 | Loop Diuretic [EPC] | 16 |
| 7 | Benzodiazepine [EPC] | 15 |
| 8 | Anti-anginal [EPC] | 14 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Anti-anginal [EPC] | 14 | 0.0013 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Anticholinergic [EPC] | 5 | 0.0003 |
| 4 | PCSK9 Inhibitor [EPC] | 6 | 0.0002 |
| 5 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 6 | 0.0002 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 7 | 0.0002 |
| 9 | Factor Xa Inhibitor [EPC] | 48 | 0.0002 |